By Yamini Kalia (Reuters) -Haleon missed third-quarter revenue and profit expectations on Thursday, partly hurt by a stronger ...

Currency fluctuations meant Haleon saw year-on-year reported revenue slip 0.6% to £2.78bn in the third quarter, below ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

She noted that the tool was able to provide insights that made Panadol’s advertising applicable in two dissimilar markets like Australia and Saudi Arabia. Haleon’s introduction of the screener comes ...

Proactive Investors - Currency fluctuations meant Haleon PLC (LSE:LON:HLN, NYSE:HLN), the FTSE 100-listed Panadol and Sensodyne owner, saw year-on-year reported revenue by 0.6% to £2.78 billion in the ...

Ben Baker, Vistar’s managing director of APAC, added that the company is proud to be selected as Haleon’s global partner for programmatic OOH. “It’s exciting to see this partnership amplify the impact ...

Consumer healthcare firm Haleon chooses Vistar Media for programmatic OOH. A decision it describes as one less headache.

Global healthcare company Haleon has chosen Vistar Media as its preferred partner for programmatic out-of-home (OOH) across ...

Haleon, a global leader in consumer healthcare, has chosen Vistar Media, the leading global provider of technology solutions ...

Q3 2024 Sales Conference Call October 31, 2024 5:00 AM ETCompany ParticipantsRakesh Patel - Director of Investor ...

Oct 31 (Reuters) - Haleon (HLN.L), opens new tab missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its painkiller Panadol in Australia ...